Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00156793 · ClinicalTrials.gov registry record · Phase 3
Phase 3 Imaging and Safety Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing SPECT Imaging
A Phase 3 study, sponsored by Acusphere.
- Completed
- Registry status
- Phase 3
- Development phase
- 400
- Enrollment target
NCT00156793: Completed Phase 3 study, sponsored by Acusphere.
NCT00156793 is a Phase 3 study that has completed, run by Acusphere. The registered enrollment target is 400 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (48% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00156793, a Phase 3 study, has completed, sponsored by Acusphere.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 400 participants
- Enrollment target
Study Summary
This study was designed to evaluate the ability of AI-700-enhanced rest-stress echocardiography to detect coronary artery disease (CAD) in patients with suspected ischemic heart disease who are indicated for single-photon emission computed tomography (SPECT) imaging.
Interventions
- PROCEDURE AI-700 contrast-enhanced echocardiography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2003-12 |
| Est. Completion | 2006-03 |
| Phase | Phase 3 |
What the finished NCT00156793 record still lists
NCT00156793 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (48% lower).
The record links to 0 conditions, and to 1 intervention - of which AI-700 contrast-enhanced echocardiography is the first listed.
NCT00156793 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00156793 about?
NCT00156793 is a clinical study titled "Phase 3 Imaging and Safety Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing SPECT Imaging". This study was designed to evaluate the ability of AI-700-enhanced rest-stress echocardiography to detect coronary artery disease (CAD) in patients with suspected ischemic heart disease who are indicated for single-photon emission computed tomography (SPECT) imaging.
What is the current status of trial NCT00156793?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 400 participants. The study started on 2003-12. Estimated completion is 2006-03.
What interventions are being tested in trial NCT00156793?
The interventions under investigation include: AI-700 contrast-enhanced echocardiography (PROCEDURE).
Who is sponsoring clinical trial NCT00156793?
This trial is sponsored by Acusphere, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00156793's enrollment target sits among peer trials
400 922nd of 2000 higher than 1,039 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia